Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-β (TGF-β) type II receptor

Oligonucleotides

Volumn 16, Issue 1, 2006, Pages 2-14

  Ogorelkova, Miroslava ^a   Zwaagstra, John ^a   Elahi, Seyyed Mehdy ^a   Dias, Christel ^a   Guilbaut, Claire ^a   Lo, Rita ^a   Collins, Cathy ^a   Jaramillo, Maria ^a   Mullick, Alaka ^a   O'Connor McCourt, Maureen ^a   Massie, Bernard ^a,b,c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY RNA; GREEN FLUORESCENT PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; CELL LINE; CELL STRAIN A549; CONTROLLED STUDY; GENE IDENTIFICATION; GENE SILENCING; GENE THERAPY; GENETIC CODE; GENETIC SCREENING; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; DOWN-REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; NUCLEIC ACID CONFORMATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; RNA, ANTISENSE; RNA, SMALL INTERFERING; TRANSFECTION;

ADENOVIRIDAE;

EID: 33645827339     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.16.2     Document Type: Article

References (48)

1. ABBAS-TERKI, T., BLANCO-BOSE, W., DEGLON, N., PRALONG, W., and AEBISCHER, P. (2002). Lentiviral-mediated RNA interference. Hum. Gene Ther. 13, 2197-2201.
2. ARIAS, M., LAHME, B., VAN DE LEUR, E., GRESSNER, A.M., and WEISKERCHEN, R. (2002). Adenoviral delivery of an antisense RNA complementary to the 3′ coding sequence of transforming growth factor-β1 inhibits fibrogenic activities of hepatic stellate cells. Cell Differ. 13, 265-273.
3. BLOBE, G.C., SCHIEMANN, W.P., and LODISH, H.F. (2000). Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358.
4. BRIDGE, A.J., PEBERNARD, S., DUCRAUX, A., NICOULAZ, A.L., and IGGO, R. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264.
5. BRUMMELKAMP, T.R., BERNARDS, R., and AGAMI, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
6. CASTANOTTO, D., LI, H., and ROSSI, J.J. (2002). Functional siRNA expression from transfected PCR products. RNA 8, 1454-1460.
7. DENNLER, S., ITOH, S., VIVIEN, D., TEN DIJKE, P., HUET, S., and GAUTHIER, J.M. (1998). Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
8. DING, Y., and LAWRENCE, C.E. (2001). Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond. Nucleic Acids Res. 29, 1034-1046.
9. DUROCHER, Y., PERRET, S., TIBAUDEAU, E. GAUMOUND, M.H., KAMEN, A., STOCCO, R., and ABRAMOVITZ, M. (2000). A reporter gene assay for high-throughput screening of G-protein coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture. Anal. Biochem. 284, 316-326.
10. ELAHI, S.M., OUALIKENE, W., NAGHDI, L., O'CONNOR-McCOURT, M., and MASSIE, B. (2002) Adenovirus-based libraries: Efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease. Gene Ther. 18, 1238-1246.
11. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
12. GABAI, V.L., VOLLOCH, V., YAGLOM, J.A., MERIIN, A.B., KOUTROUMANIS, M., MASSIE, B., MOSSER, D.D., and SHERMAN, M.Y. (2000). Hsp72-mediated suppression of stress-kinase JNK is implicated in development of tolerance to caspase-independent cell death. Mol. Cell. Biol. 20, 6826-6836.
13. GONDI, C.S., LAKKA, S.S., NIRANJAN, Y., SIDDIQUE, K., DINH, D.D., OLIVERO, W.C., GUJRATI, M., and RAO, J.S. (2003). Expression of antisense uPAR and antisense uPA from a biscistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22, 5967-5975.
14. HABERMAN, R.P., CRISWELL, H.E., SNOWDY, S., MING, Z., BREESE, G.R., SAMULSKI, R.J., and McCOWN, T.J. (2002). Therapeutic liabilities of in vivo viral vector tropism: Adeno-associated virus vectors, NMDAR1 antisense and focal seizure sensitivity. Mol. Ther. 6, 495-500.
15. HOLEN, T., AMARZGUIOUI, M., WIIGER, M.T., BABAIE, E., and PRYDZ, H. (2002). Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30, 1757-1766.
16. KIM, D.H., LONGO, M., HAN, Y., LUNDBERG, P., CANTIN, E., and ROSSI, J.J. (2004). Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321-325.
17. KUMAR, M., and CARMICHAEL, G.G. (1997). Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. USA 94, 3542-3547.
18. KUMAR, M., and CARMICHAEL, G.G. (1998). Antisense RNA: Function and fate of duplex RNA in cells of higher eukaryotes. Microbiol. Mol. Biol. Rev. 62, 1415-1434.
19. KUMAR, R., CONKLIN, D.S., and MITTAL, V. (2003). High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 13, 2333-2340.
20. LAWRENCE, D.A. (1996). Transforming growth factor-beta: A general review. Eur. Cytokine Netw. 7, 363-374.
21. LEE, N.S., DOHJIMA, T., BAUER, G., LI, H., LI, M.J., EHSANI, A., SALVATERRA, P., and ROSSI, J. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500-505.
22. LEHMANN, M.J., PATZEL, V., and SCZAKIEL, G. (2000). Theoretical design of antisense genes with statistically increased efficacy. Nucleic Acids Res. 28, 2597-2604.
23. LI, G.C., HE, F., SHAO, X., URANO, M., SHEN, L., KIM, D., BORRELLI, M., LEIBEL, S.A., GUTLIN, P.H., and LING, C.C. (2003). Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res. 63, 3268-3274.
24. MASSAGUÉ, J., BLAIN, S.W., and LO, R.S. (2000). TGFβ signaling in growth control, cancer and heritable disorders. Cell 103, 295-309.
25. MASSIE, B., MOSSER, D.D., KOUTROUMANIS, M., VITTÉ-MONY, I., LAMOUREUX, L., COUTURE, F., PAQUET, L., GUILBAULT, C., DIONNE, J., CHALA, D., JOLICOEUR, P., and LANGELIER, Y. (1998). New adenovirus vectors for protein production and gene transfer. Cytotechnology 28, 53-64.
26. MITCHELL, E.J., and O'CONNOR-McCOURT, M.D. (1991). A transforming growth factor beta (TGF-beta) receptor from human placenta exhibits a greater affinity for TGF-beta 2 than for TGF-beta 1. Biochemistry 30, 4350-4356.
27. MIYAGISHI, M., HAYASHI, M., and TAIRA, K. (2003). Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev. 13, 1-7.
28. MOSSER, D.D., CARON, A.W., BOURGET, L., JOLICOEUR, P., and MASSIE, B. (1997). Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. Biotechniques 22, 150-154.
29. NAGY, P., ARNDT-JOVIN, D.J., and JOVIN, T.M. (2003). Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp. Cell Res. 285, 39-49.
30. NAKANO, M., AOKI, K., MATSUMOTO, N., OHNAMI, S., HATANAKA, K., HIBI, T., TERADA, M., and YUSHIDA, T. (2001). Supression of colorectal cancer growth using an adeovirus vector expressing an antisense K-ras RNA. Mol. Ther. 3, 491-499.
31. OGASA, H., NOMA, T., MURATA, H., KAWAI, S., and NAKAZAWA, A. (1996). Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: Heterogeneity of the mRNA. Gene 181, 185-190.
32. OGORELKOVA, M., ELHAI, S.M., GAGNON, D., and MASSIE, B. (2003). DNA delivery to cell in culture: Generation of adenoviral libraries for high throughput functional screening. In: Methods in Molecular Biology entitled Gene Transfer to Mammalian Cells. W.C. Heiser, ed. (Humana Press, Inc., Totowa, NJ), pp. 15-27.
33. OHKAWA, J., and TAIRA, K. (2000). Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter. Hum. Gene Ther. 11, 577-585.
34. OHNAMI, S., AOKI, K., YOSHIDA, K., OHNAMI, S., HATANAKA, K., SUZUKI, K., SASAKI, H., and YOSHIDA, T. (2003). Expression profiles of pancratic cancer cell lines infected with antisense K-ras-expressing adenoviral vector. Biochem. Biophys. Res. Commun. 309, 798-803.
35. PADDISON, P.J., and HANNON, G.J. (2002). RNA interference: The new somatic cell genetics? Cancer Cell 2, 17-23.
36. PATZEL, V., and SCZAKIEL, G. (1998). Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells. Nat. Biotechnol. 16, 64-68.
37. PFAFFL, M.W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
38. RASMUSSEN, R. (2001). Quantification on the LightCycler. In: S. Meuer, C. Wittwer, K. Nakagawara, eds. Rapid Cycle Real-Time PCR, Methods and Applications. (Springer Press, Heidelberg), pp. 21-34.
39. SCZAKIEL, G. (1997). The design of antisense RNA. Antisense Nucleic Acid Drug Dev. 7, 439-444.
40. SCZAKIEL, G., and FAR, R.K. (2002). The role of target accessibility for antisense inhibition. Curr. Opin. Mol. Ther. 4, 149-153.
41. SHEN, C., BUCK, A.K., LIU, X., WINKLER, M., and RESKE, S.N. (2003). Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 539, 111-114.
42. SHI, Y. (2003). Mammalian RNAi for the masses. Trends Genet. 19, 9-12.
43. SLEDZ, C.A., HOLKO, M., DE VEER, M.J., SILVERMAN, R.H., and WILLIAMS, B.R.G. (2003). Activation of the interferon system by short interfering RNAs. Nat. Cell Biol. 5, 771-772.
44. T'HOEN, P.A., ROSEMA, B.S., COMMANDEUR, J.N., VERMEULEN, N.P., MANOHARAN, M., VAN BERKEL, T.J., BIESSEN, E.A., and BIJSTERBOSCH, M.K. (2002). Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay. Discovery of selective and potent inhibitors of glutathione S-transferase Mu expression. Eur. J. Biochem. 269, 2574-2583.
45. TUSCHL, T., ELBASHIR, S., HARBORTH, J., and WEBER, K. (2002). The siRNA user guide, at www.mpibpc.gwdg.de/abteilungen/100/105/sirna.html.
46. WEISS, B., DAVIDKOVA, G., and ZHOU, L.W. (1999). Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. 55, 334-358.
47. YU, J.Y., DERUITER, S.L., and TURNER D.L. (2002). RNA interference by expression of short interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 6047-6052.
48. ZHANG, X., CHEN, Z., CHEN, Y., and TONG, T. (2003). Delivering antisense telomerase RNA by a hybrid adenovirus/adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells. Oncogene 22, 2405-2416.